Skip to main content

Table 1 Drug susceptibility results of the MFC isolate

From: Successful bedaquiline-containing antimycobacterial treatment in post-traumatic skin and soft-tissue infection by Mycobacterium fortuitum complex: a case report

Substance

MIC

Interpretation

Moxifloxacin

0.25 mg / L

S

Ciprofloxacin

0.5 mg / L

S

Amikacin

4.0 mg / L

S

Linezolid

32.0 mg / L

R

Clarithromycin

16.0 mg / L

R

Imipenem

8.0 mg / L

I

Cefoxitin

128 mg / L

R

Doxycycline

16.0 mg / L

R

Minocyclin

8.0 mg / L

R

Cotrimoxazol

8/152 mg / L

R

Tigecyclin

0.5 mg / L

No breakpoints available

Clofazimine

0.06 mg / L

No breakpoints available

Bedaquiline

0.015 mg / L

No breakpoints available

Delamanid

>  0.5 mg  / L

No breakpoints available